Revenue
3.69 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 3686000 USD Source
Fundies. English
NEXGEL, INC.
EDGARAnnual consolidated revenue for 2025: about USD 11.42M, using the latest reported figures. The previous period, 2024, was about USD 8.688M.
Latest quarter
Operating margin
-67.96%
2026 Q2 · %
Operating cash flow
-2.2 million USD
2026 Q2 · USD
- Cash and cash equivalents
- 938 thousand USD Source
Exact value
938000 USD
- Long-term debt including current maturities
- 563 thousand USD Source
Exact value
563000 USD
- Shares outstanding
- 9.7 million shares Source
Exact value
9700022 shares
Reported share-count change
26.72% · 2.05 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
12.1 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-20.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 4 of 11 periods available· newest 2025-12-31
- Operating income: 5 of 11 periods available· newest 2025-12-31
- Net income: 5 of 11 periods available· newest 2025-12-31
- Operating cash flow: 5 of 11 periods available· newest 2025-12-31
- Capital expenditure: 5 of 11 periods available· newest 2025-12-31
- Total assets: 4 of 11 periods available· newest 2025-12-31
- Total liabilities: 4 of 11 periods available· newest 2025-12-31
- Current assets: 4 of 11 periods available· newest 2025-12-31
- Current liabilities: 4 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2024-12-31
- Long-term debt including current maturities: 4 of 11 periods available· newest 2025-12-31
- Shares outstanding: 4 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+31.5%Prior period
USD 8.69 million
–
Current period
USD 11.42 million
–
Exact inputs and evidence
11421000 − 8688000 = 2733000 USD
8688000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source11421000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 281,000Prior period
−USD 3.28 million
–
Current period
−USD 3 million
–
Exact inputs and evidence
-3000000 − -3281000 = 281000 USD
-3281000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-3000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.57 millionPrior period
−USD 3.87 million
–
Current period
−USD 1.3 million
–
Exact inputs and evidence
-1300000 − -3867000 = 2567000 USD
-3867000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-1300000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-84.7%Prior period
USD 443,000
–
Current period
USD 68,000
–
Exact inputs and evidence
68000 − 443000 = -375000 USD
443000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source68000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 11.42 million 100% of revenue
- Cost of revenue USD 6.91 million 61% of revenue
- Operating expenses USD 7.86 million 69% of revenue
- Operating income −USD 3.35 million −29% of revenue
- Tax, interest and other Derived −USD 352,000 −3.1% of revenue
- Net income −USD 3 million −26% of revenue
Cash
- Operating cash flow −USD 1.3 million −11% of revenue
- Capital expenditure USD 68,000 0.6% of revenue
- Free cash flow Derived −USD 1.37 million −12% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2022 Operating loss: operating costs were 263% of revenue.
- 2023 Operating loss: operating costs were 185% of revenue.
- 2024 Operating loss: operating costs were 141% of revenue.
- 2025 Operating loss: operating costs were 129% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 2048000 | 5396000 Derived | -3348000 | 1398000 Derived | -4746000 | -3088000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 4089000 | 7566000 Derived | -3477000 | -320000 Derived | -3157000 | -3932000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 8688000 | 12242000 Derived | -3554000 | -273000 Derived | -3281000 | -4310000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 11421000 | 14773000 Derived | -3352000 | -352000 Derived | -3000000 | -1368000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 11.4M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 2048000 |
|
| 2023 | Revenue | 4089000 |
|
| 2024 | Revenue | 8688000 |
|
| 2025 | Revenue | 11421000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
31.5% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 99.7% |
|
| 2024 | Year over year | 112.5% |
|
| 2025 | Year over year | 31.5% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -29.3% 2025
Net margin -26.3% 2025
Free cash flow margin -12% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | -163.5% |
|
| 2023 | Operating margin | -85% |
|
| 2024 | Operating margin | -40.9% |
|
| 2025 | Operating margin | -29.3% |
|
| 2022 | Net margin | -231.7% |
|
| 2023 | Net margin | -77.2% |
|
| 2024 | Net margin | -37.8% |
|
| 2025 | Net margin | -26.3% |
|
| 2022 | Free cash flow margin | -150.8% |
|
| 2023 | Free cash flow margin | -96.2% |
|
| 2024 | Free cash flow margin | -49.6% |
|
| 2025 | Free cash flow margin | -12% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -1.3M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | -2992000 |
|
| 2023 | Operating cash flow | -3236000 |
|
| 2024 | Operating cash flow | -3867000 |
|
| 2025 | Operating cash flow | -1300000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -1.4M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | -3088000 |
|
| 2023 | Free cash flow | -3932000 |
|
| 2024 | Free cash flow | -4310000 |
|
| 2025 | Free cash flow | -1368000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
53.2% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Liabilities / assets | 26.3% |
|
| 2023 | Liabilities / assets | 48.1% |
|
| 2024 | Liabilities / assets | 44.6% |
|
| 2025 | Liabilities / assets | 53.2% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
1.47× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Current assets / current liabilities | 8.74× |
|
| 2023 | Current assets / current liabilities | 1.98× |
|
| 2024 | Current assets / current liabilities | 2.07× |
|
| 2025 | Current assets / current liabilities | 1.47× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 4.31 million Exact valueExact value: -4310000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.75 million Exact valueExact value: -2753000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 269,000 Exact valueExact value: 269000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.02 million Calculation and evidence-2753000 − 269000 USD Exact free cash flow: -3022000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 4.75 million Exact valueExact value: -4746000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.99 million Exact valueExact value: -2992000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 96,000 Exact valueExact value: 96000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.09 million Calculation and evidence-2992000 − 96000 USD Exact free cash flow: -3088000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 3.16 million Exact valueExact value: -3157000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.24 million Exact valueExact value: -3236000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 696,000 Exact valueExact value: 696000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.93 million Calculation and evidence-3236000 − 696000 USD Exact free cash flow: -3932000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 3.28 million Exact valueExact value: -3281000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.87 million Exact valueExact value: -3867000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 443,000 Exact valueExact value: 443000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.31 million Calculation and evidence-3867000 − 443000 USD Exact free cash flow: -4310000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 3 million Exact valueExact value: -3000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.3 million Exact valueExact value: -1300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 68,000 Exact valueExact value: 68000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.37 million Calculation and evidence-1300000 − 68000 USD Exact free cash flow: -1368000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
45 filings · 3,379 latest values · 3,379 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001468929, 1468929, NXGL, NXGLW, edgar:1468929
Also known as AquaMed Technologies, Inc., NEXGEL, INC., NEXGEL, INC., NexGel, Inc., NexGel, Inc.